Description of Research: Curtis Collins,
Dr. Collins is an Infectious Diseases Clinical Pharmacy
Specialist at the University of Michigan Health System.
Much of his research focuses on the pharmacoeconomic
assessment of new antimicrobial agents, the financial
impact of infectious disease states, and investigating
cost-effective antimicrobial treatment strategies.
Other research deals with outcomes associated with
antimicrobial stewardship programs and the effect
such programs have on improving patient care, optimizing
antimicrobial use, and attenuating or reversing advancing
antimicrobial resistance. Dr. Collins is also involved
with local, regional, and state emergency preparedness
efforts and has performed research in the area of
historical pandemic influenza response.
Steele BJ, Collins CD. La Grippe and World War I:
Conflict Participation and Pandemic Confrontation.
Global Public Health, In Press.
Shehab N, DePestel DD, Mackler ER, Collins CD, Welch
K, Erba HP. Institutional Experience with Voriconazole
Compared to Liposomal Amphotericin B as Empirical
Therapy in Adult Hematology Patients after Implementation
of a Febrile Neutropenia Algorithm. Pharmacotherapy.
Collins CD, Eschenauer GA, Salo SL, Newton DW. To
test or not to test: A cost-minimization analysis
of susceptibility testing in patients with Candida
Glabrata fungemias. J Clin Microbiol. 2007;45: 1884-1888.
Collins CD, Stuntebeck ER, DePestel DD, Stevenson
JG. Pharmacoeconomic Analysis of Liposomal Amphotericin
B versus Voriconazole for Empiric Treatment of Febrile
Neutropenia. Clin Drug Invest 2007;27(4):233-241.
Eschenaur GA, Fedewa K, Collins CD, Alaniz C. Compliance
with institutional guidelines on the use of vancomycin
in a medical intensive care unit. Hosp Pharm. 2006;41:749-753.
Collins CD, Pedersen CA, Schneider PJ, Sierawski
SJ, Miller AS, Roux RK. Effect of a Clinical Decision
Support System in Computerized Prescriber Order Entry
on Amphotericin B Lipid Complex Use. Am J Health-Syst
Pharm. 2004; 61: 1395-99.